А В Кравченко

479 total citations
35 papers, 381 citations indexed

About

А В Кравченко is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, А В Кравченко has authored 35 papers receiving a total of 381 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Infectious Diseases, 16 papers in Virology and 15 papers in Epidemiology. Recurrent topics in А В Кравченко's work include HIV Research and Treatment (16 papers), HIV/AIDS drug development and treatment (16 papers) and Hepatitis C virus research (9 papers). А В Кравченко is often cited by papers focused on HIV Research and Treatment (16 papers), HIV/AIDS drug development and treatment (16 papers) and Hepatitis C virus research (9 papers). А В Кравченко collaborates with scholars based in Russia, Germany and United Kingdom. А В Кравченко's co-authors include Vadim Pokrovsky, Aleksei F. Bobkov, Elena Kazennova, Jonathan Weber, LUDMILA SELIMOVA, N. N. Ladnaya, Bobkova Mr, Rachanee Cheingsong‐Popov, Anna L. Sukhanova and R. Cheingsong‐Popov and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Clinical Microbiology and Journal of Medical Virology.

In The Last Decade

А В Кравченко

30 papers receiving 354 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
А В Кравченко Russia 10 309 263 191 67 48 35 381
LUDMILA SELIMOVA Russia 7 291 0.9× 234 0.9× 178 0.9× 68 1.0× 43 0.9× 10 337
N. N. Ladnaya Russia 10 293 0.9× 280 1.1× 214 1.1× 63 0.9× 56 1.2× 20 391
Yuka Nadai United States 10 238 0.8× 222 0.8× 109 0.6× 25 0.4× 14 0.3× 13 286
Tiina Laukkanen Finland 9 386 1.2× 317 1.2× 140 0.7× 57 0.9× 13 0.3× 12 429
Aleksei F. Bobkov Russia 13 572 1.9× 476 1.8× 282 1.5× 117 1.7× 64 1.3× 30 672
Elena Kazennova Russia 14 606 2.0× 481 1.8× 338 1.8× 98 1.5× 120 2.5× 56 709
Saulius Chaplinskas Lithuania 4 162 0.5× 170 0.6× 195 1.0× 158 2.4× 10 0.2× 6 324
Stijn Imbrechts Belgium 5 307 1.0× 282 1.1× 98 0.5× 21 0.3× 7 0.1× 6 348
Makiko Kondo Japan 10 220 0.7× 218 0.8× 73 0.4× 30 0.4× 6 0.1× 30 280
Gema Casado Spain 9 344 1.1× 294 1.1× 110 0.6× 18 0.3× 9 0.2× 12 361

Countries citing papers authored by А В Кравченко

Since Specialization
Citations

This map shows the geographic impact of А В Кравченко's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by А В Кравченко with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites А В Кравченко more than expected).

Fields of papers citing papers by А В Кравченко

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by А В Кравченко. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by А В Кравченко. The network helps show where А В Кравченко may publish in the future.

Co-authorship network of co-authors of А В Кравченко

This figure shows the co-authorship network connecting the top 25 collaborators of А В Кравченко. A scholar is included among the top collaborators of А В Кравченко based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with А В Кравченко. А В Кравченко is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Кравченко, А В, et al.. (2021). Cutaneous and visceral leishmaniasis in patients with HIV infection in Russia. Case report. Terapevticheskii arkhiv. 93(11). 1363–1367. 1 indexed citations
2.
Кравченко, А В, et al.. (2020). Evaluating the safety, tolerability, pharmacokinetics, and drug interactions of elsulfavirine in healthy volunteers and patients with liver disorders. Infekcionnye bolezni. 18(2). 40–46. 1 indexed citations
3.
Кравченко, А В, et al.. (2020). Leishmaniasis and HIV-infection – an actual problem?. SHILAP Revista de lepidopterología. 12(4). 72–77. 1 indexed citations
4.
Кравченко, А В, et al.. (2019). THE IMPACT OF SUBSTANCE ABUSE ON THE DEVELOPMENT OF ACTIVE TUBERCULOSIS IN HIV POSITIVE PATIENTS DEPENDING ON THEIR CD4 COUNT. Tuberculosis and lung diseases. 97(4). 19–24.
5.
Кравченко, А В, et al.. (2019). Analysis of prevalence of HIV-1 primary resistance to antiretroviral drugs in the territory of Moscow and Moscow region. SHILAP Revista de lepidopterología. 96(3). 27–31. 1 indexed citations
6.
Кравченко, А В, et al.. (2018). Comparison of efficacy and safety of antiretroviral first-line therapy with phosphazideortdf. Journal Infectology. 10(4). 37–41. 1 indexed citations
7.
Кравченко, А В, et al.. (2016). Prevalence of high oncogenic risk genotypes of human papillomavirus in HIV-positive and HIV-negative females. Infekcionnye bolezni. 14(4). 26–30. 3 indexed citations
8.
Кравченко, А В. (2016). Modern antiretroviral regimens. Meditsinskiy sovet = Medical Council. 84–89. 1 indexed citations
10.
Кравченко, А В, et al.. (2014). [The efficacy and safety of a therapy regimen including raltegravir and a fixed dose combination of lamivudine and abacavir in previously rifabutin-treated patients with tuberculosis and HIV infection].. PubMed. 86(11). 34–41. 1 indexed citations
13.
Кравченко, А В, et al.. (2011). [Diagnosis of tuberculous pericarditis in patients with HIV-infection].. PubMed. 83(11). 14–9. 1 indexed citations
14.
Кравченко, А В, et al.. (2003). Development of approaches to enhancing adherence of patients withhuman immunodeficiency virus infection to antiretrovirustherapy. SHILAP Revista de lepidopterología. 78(11). 36–38. 1 indexed citations
15.
Bobkov, Aleksei F., Elena Kazennova, Bobkova Mr, et al.. (2001). An HIV Type 1 Subtype A Strain of Low Genetic Diversity Continues to Spread among Injecting Drug Users in Russia: Study of the New Local Outbreaks in Moscow and Irkutsk. AIDS Research and Human Retroviruses. 17(3). 257–261. 49 indexed citations
16.
Bobkov, Aleksei F., Elena Kazennova, LUDMILA SELIMOVA, et al.. (1998). A Sudden Epidemic of HIV Type 1 among Injecting Drug Users in the Former Soviet Union: Identification of Subtype A, Subtype B, and Novel gag A/ env B Recombinants. AIDS Research and Human Retroviruses. 14(8). 669–676. 87 indexed citations
17.
Bobkov, Aleksei F., Rachanee Cheingsong‐Popov, LUDMILA SELIMOVA, et al.. (1997). HIV Type 1 Subtype E in Russia. AIDS Research and Human Retroviruses. 13(8). 725–727. 10 indexed citations
18.
Bobkov, Aleksei F., Rachanee Cheingsong‐Popov, LUDMILA SELIMOVA, et al.. (1997). An HIV Type 1 Epidemic among Injecting Drug Users in the Former Soviet Union Caused by a Homogeneous Subtype A Strain. AIDS Research and Human Retroviruses. 13(14). 1195–1201. 75 indexed citations
19.
Bobkov, Aleksei F., Rachanee Cheingsong‐Popov, LUDMILA SELIMOVA, et al.. (1996). Sequence Note : Sequence Analysis of the Glycoprotein 120 Coding Region of a New Human Immunodeficiency Virus Type 1 Subtype G Strain from Russia. AIDS Research and Human Retroviruses. 12(14). 1385–1388. 11 indexed citations
20.
Bobkov, Aleksei F., R. Cheingsong‐Popov, LUDMILA SELIMOVA, et al.. (1996). Genetic Heterogeneity of HIV Type 1 in Russia: Identification of H Variants and Relationship with Epidemiological Data. AIDS Research and Human Retroviruses. 12(18). 1687–1690. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026